Genome-wide microRNA Analysis Identified<i> miR-210-3p</i> Over-expression in Pancreatic Cancer Tissues as a Predictor of their Local Invasiveness

Otsu, T; Hayashi, M; Fujita, K; Kobayashi, D; Nakagawa, N; Kurimoto, K; Takami, H; Nakanishi, K; Umeda, S; Shimizu, D; Hattori, N; Kanda, M; Tanaka, C; Nakayama, G; Kodera, Y

ANTICANCER RESEARCH   44 巻 ( 11 ) 頁： 4709 - 4721   2024年11月

Catheter-related bloodstream infection caused by Lacticaseibacillus paracasei: A case report and literature review

Fukuda, Y; Morioka, H; Yamamoto, S; Iguchi, M; Umeda, S; Asahara, T; Kanda, K; Oka, K; Nakayama, G; Yagi, T

JOURNAL OF INFECTION AND CHEMOTHERAPY   30 巻 ( 7 ) 頁： 664 - 667   2024年7月

Prognostic Impact of <i>CDKN2A</i> Mutations Associated With Smoking and Drinking History in Japanese Digestive Cancers

Fujita, K; Hayashi, M; Nakagawa, N; Kurimoto, K; Inokawa, Y; Takami, H; Nakanishi, K; Umeda, S; Shimizu, D; Hattori, N; Kanda, M; Tanaka, C; Nakayama, G; Kodera, Y

ANTICANCER RESEARCH   44 巻 ( 6 ) 頁： 2699 - 2707   2024年6月

Chronologic improvement in survival of first-line oxaliplatin based chemotherapy plus targeted therapy for metastatic colorectal cancer (mCRC): Analysis of the ARCAD database

Takeda, Y; Yamazaki, K; Saltz, L; Douillard, JY; Punt, CJA; Van Cutsem, E; Bokemeyer, C; Venook, A; Koopman, M; Heinemann, V; Cremolini, C; Hecht, JR; Schmoll, HJEV; Nakayama, G; Sugihara, K; Oki, E; André, T; Shi, Q; De Gramont, A; Yoshino, T

ANNALS OF ONCOLOGY   35 巻   頁： S38 - S38   2024年6月

ASO Visual Abstract: Absence of Hypercoagulation Status After Neoadjuvant Treatment is Associated with Favorable Prognosis in Patients Undergoing Subtotal Esophagectomy for Esophageal Squamous Cell Carcinoma

Sugiyama, F; Kanda, M; Shimizu, D; Umeda, S; Inokawa, Y; Hattori, N; Hayashi, M; Tanaka, C; Nakayama, G; Kodera, Y

ANNALS OF SURGICAL ONCOLOGY   31 巻 ( 5 ) 頁： 3477 - 3478   2024年5月

Absence of Hypercoagulation Status after Neoadjuvant Treatment is Associated with Favorable Prognosis in Patients Undergoing Subtotal Esophagectomy for Esophageal Squamous Cell Carcinoma

Sugiyama, F; Kanda, M; Shimizu, D; Umeda, S; Inokawa, Y; Hattori, N; Hayashi, M; Tanaka, C; Nakayama, G; Kodera, Y

ANNALS OF SURGICAL ONCOLOGY   31 巻 ( 5 ) 頁： 3417 - 3425   2024年5月

Killer cell lectin-like receptor G2 facilitates aggressive phenotypes of gastric cancer cells via dual activation of the ERK1/2 and JAK/STAT pathways

Ito, Y; Kanda, M; Sasahara, M; Tanaka, C; Shimizu, D; Umeda, S; Inokawa, Y; Hattori, N; Hayashi, M; Nakayama, G; Kodera, Y

GASTRIC CANCER   27 巻 ( 3 ) 頁： 506 - 518   2024年5月

Outcomes of surgical treatment for enterovesical fistula in Crohn's disease.

Hattori N, Nakayama G, Umeda S, Nakamura M, Yamamura T, Sawada T, Nakanishi K, Shimizu D, Kanda M, Hayashi M, Tanaka C, Kodera Y

Nagoya journal of medical science   86 巻 ( 2 ) 頁： 280 - 291   2024年5月

Therapeutic antibody targeting natriuretic peptide receptor 1 inhibits gastric cancer growth <i>via</i> BCL-2-mediated intrinsic apoptosis

Sasahara, M; Kanda, M; Tanaka, C; Shimizu, D; Umeda, S; Takami, H; Inokawa, Y; Hattori, N; Hayashi, M; Nakayama, G; Kodera, Y

INTERNATIONAL JOURNAL OF CANCER   154 巻 ( 7 ) 頁： 1272 - 1284   2024年4月

Risk Factors for Long-term Body Weight Loss After Proximal Gastrectomy: A Retrospective Analysis

Agatsuma, Y; Nakanishi, K; Tanaka, C; Kanda, M; Shimizu, D; Umeda, S; Kurimoto, K; Inokawa, Y; Takami, H; Hattori, N; Hayashi, M; Nakayama, G; Fujiwara, M; Kodera, Y

ANTICANCER RESEARCH   44 巻 ( 4 ) 頁： 1645 - 1651   2024年4月

Increased STX3 transcript and protein levels were associated with poor prognosis in two independent cohorts of esophageal squamous cell carcinoma patients

Shinozuka, T; Kanda, M; Sato, Y; Shimizu, D; Tanaka, C; Umeda, S; Inokawa, Y; Hattori, N; Hayashi, M; Nakayama, G; Kodera, Y

CANCER MEDICINE   12 巻 ( 24 ) 頁： 22185 - 22195   2023年12月

Predictive impacts of peritoneal washing cytology for surgical resection-intended pancreatic cancer cases: Establishment of planned staging laparoscopy criteria

Tanaka, N; Takami, H; Hayashi, M; Inokawa, Y; Kurimoto, K; Hattori, N; Kanda, M; Tanaka, C; Nakayama, G; Kodera, Y

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES   30 巻 ( 11 ) 頁： 1273 - 1281   2023年11月

Risk Stratification by Tissue<i> GAD1</i> Expression Level in Curatively Resected Esophageal Squamous Cell Carcinoma

Kishida, T; Kanda, M; Sato, Y; Shimizu, D; Inokawa, Y; Hattori, N; Hayashi, M; Tanaka, C; Nakayama, G; Kodera, Y

CANCER GENOMICS & PROTEOMICS   20 巻 ( 6 ) 頁： 617 - 625   2023年11月

Identification of stromal cell-derived factor 4 as a liquid biopsy-based diagnostic marker in solid cancers

Shinozuka, T; Kanda, M; Shimizu, D; Umeda, S; Takami, H; Inokawa, Y; Hattori, N; Hayashi, M; Tanaka, C; Nakayama, G; Kodera, Y

SCIENTIFIC REPORTS   13 巻 ( 1 ) 頁： 15540   2023年9月

A proposed new Japanese classification of synchronous peritoneal metastases from colorectal cancer: A multi-institutional, prospective, observational study conducted by the Japanese Society for Cancer of the Colon and Rectum

Kobayashi, H; Kotake, K; Kawasaki, M; Kanemitsu, Y; Kinugasa, Y; Ueno, H; Maeda, K; Suto, T; Itabashi, M; Funahashi, K; Ozawa, H; Koyama, F; Noura, S; Ishida, H; Ohue, M; Kiyomatsu, T; Ishihara, S; Koda, K; Baba, H; Kawada, K; Hashiguchi, Y; Goi, T; Toiyama, Y; Tomita, N; Sunami, E; Akagi, Y; Watanabe, J; Hakamada, K; Nakayama, G; Sugihara, K; Ajioka, Y

ANNALS OF GASTROENTEROLOGICAL SURGERY   7 巻 ( 5 ) 頁： 765 - 771   2023年9月

The preoperative systemic immune-inflammation index is associated with an unfavorable prognosis for patients undergoing curative resection of esophageal squamous cell carcinoma after neoadjuvant therapy

Obata, Y; Kanda, M; Shimizu, D; Takami, H; Inokawa, Y; Hattori, N; Hayashi, M; Tanaka, C; Nakayama, G; Kodera, Y

SURGERY TODAY   53 巻 ( 8 ) 頁： 964 - 972   2023年8月

High Preoperative Platelet to Lymphocyte Ratio is Associated with a Greater Risk of Postoperative Complications and Hematogenous Recurrences in Esophageal Squamous Cell Carcinoma Patients Receiving Neoadjuvant Treatment

Sasahara, M; Kanda, M; Shimizu, D; Takami, H; Inokawa, Y; Hattori, N; Hayashi, M; Tanaka, C; Fujiwara, M; Nakayama, G; Kodera, Y

DIGESTIVE SURGERY   40 巻 ( 1-2 ) 頁： 48 - 57   2023年7月

High Preoperative Serum D-dimer Predicts Unfavorable Survival Outcomes for Pancreatic Cancer Patients

Otsu, T; Hayashi, M; Takami, H; Inokawa, Y; Tanaka, N; Kurimoto, K; Nakanishi, K; Umeda, S; Shimizu, D; Hattori, N; Kanda, M; Tanaka, C; Nakayama, G; Kodera, Y

ANTICANCER RESEARCH   43 巻 ( 7 ) 頁： 3173 - 3181   2023年7月

Optimal molecular-targeted therapies as first-line treatment for <i>RAS</i> wild-type, right-sided metastatic colorectal cancer from the Analysis and Research in Cancers of the Digestive System (ARCAD) database

Yamazaki, K; Takeda, Y; Misumi, T; Suzuki, M; Wakabayashi, M; Bando, H; Oki, E; Douillard, JY; Punt, CJA; Van Cutsem, E; Bokemeyer, C; Venook, AP; Maehara, Y; Heinemann, V; Cremolini, C; Nakayama, G; Andre, T; Shi, Q; De Gramont, A; Yoshino, T

JOURNAL OF CLINICAL ONCOLOGY   41 巻 ( 16 )   2023年6月

Albumin-Globulin Ratio Indicates the Survival Outcome of Pancreatic Cancer Cases Who Underwent Preoperative Treatment and Curative Surgical Resection

Hayashi, M; Kobayashi, D; Takami, H; Inokawa, Y; Tanaka, N; Kurimoto, K; Nakanishi, K; Umeda, S; Shimizu, D; Hattori, N; Kanda, M; Tanaka, C; Nakayama, G; Kodera, Y

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL   75 巻 ( 5 ) 頁： 1330 - 1339   2023年5月

Molecular genetic positioning of small intestine and papilla of Vater carcinomas including clinicopathological classification

Nakamura, M; Okamura, Y; Ohshima, K; Sugiura, T; Ashida, R; Ohgi, K; Bando, E; Fujiya, K; Shiomi, A; Kagawa, H; Imamura, T; Nakayama, G; Kodera, Y; Uesaka, K; Ohike, N; Norose, T; Sasaki, K; Sugino, T; Ohnami, S; Nagashima, T; Urakami, K; Akiyama, Y; Yamaguchi, K

CANCER MEDICINE   12 巻 ( 10 ) 頁： 11491 - 11502   2023年5月

Impact of obstructive ventilatory impairment on intraoperative bleeding during laparoscopic hepatectomy

Nakamura, M; Okamura, Y; Sugiura, T; Ashida, R; Ohgi, K; Yamada, M; Otsuka, S; Nakayama, G; Kodera, Y; Uesaka, K

LANGENBECKS ARCHIVES OF SURGERY   408 巻 ( 1 ) 頁： 122   2023年3月

Perioperative changes in geriatric functions of elderly patients undergoing surgical resection for gastric cancer.

Tanaka, C; Kanda, M; Nakanishi, K; Umeda, S; Shimizu, D; Inokawa, Y; Takami, H; Hayashi, M; Nakayama, G; Fujiwara, M; Kodera, Y; Hattori, N

JOURNAL OF CLINICAL ONCOLOGY   41 巻   頁： 811 - 811   2023年2月

Proposal of a coagulation score to predict postoperative survival of patients undergoing neoadjuvant therapy followed by subtotal esophagectomy for squamous cell carcinoma of the esophagus.

Sugiyama, F; Shimizu, D; Kanda, M; Tanaka, C; Takami, H; Inokawa, Y; Hattori, N; Hayashi, M; Nakayama, G; Fujiwara, M; Kodera, Y

JOURNAL OF CLINICAL ONCOLOGY   41 巻   頁： 448 - 448   2023年2月

Controlling Nutritional Status Score Serves as a Prognosticator in Esophageal Squamous Cell Carcinoma: Optimal Timing of Evaluation of Patients Undergoing Neoadjuvant Treatment

Nonogaki, I; Kanda, M; Shimizu, D; Inokawa, Y; Hattori, N; Hayashi, M; Tanaka, C; Koike, M; Nakayama, G; Kodera, Y

WORLD JOURNAL OF SURGERY   47 巻 ( 1 ) 頁： 217 - 226   2023年1月

The effects of ustekinumab on small intestinal lesions and stenotic lesions

Wada, H; Murate, K; Nakamura, M; Furukawa, K; Kakushima, N; Yamamura, T; Maeda, K; Sawada, T; Ishikawa, E; Ishikawa, T; Ohno, E; Honda, T; Kawashima, H; Nakayama, G; Hattori, N; Umeda, S; Ishigami, M

NAGOYA JOURNAL OF MEDICAL SCIENCE   84 巻 ( 4 ) 頁： 825 - 838   2022年11月

ASO Visual Abstract: Downregulation of ROBO4 in Pancreatic Cancer Serves as a Biomarker of Poor Prognosis and Indicates Increased Cell Motility and Proliferation Through Activation of MMP-9

Yamanaka, M; Hayashi, M; Sonohara, F; Yamada, S; Tanaka, H; Sakai, A; Mii, S; Kobayashi, D; Kurimoto, K; Tanaka, N; Inokawa, Y; Takami, H; Hattori, N; Kanda, M; Tanaka, C; Nakayama, G; Koike, M; Kodera, Y

ANNALS OF SURGICAL ONCOLOGY   29 巻 ( 11 ) 頁： 7192 - 7193   2022年10月

Downregulation of ROBO4 in Pancreatic Cancer Serves as a Biomarker of Poor Prognosis and Indicates Increased Cell Motility and Proliferation Through Activation of MMP-9

Yamanaka, M; Hayashi, M; Sonohara, F; Yamada, S; Tanaka, H; Sakai, A; Mii, S; Kobayashi, D; Kurimoto, K; Tanaka, N; Inokawa, Y; Takami, H; Hattori, N; Kanda, M; Tanaka, C; Nakayama, G; Koike, M; Kodera, Y

ANNALS OF SURGICAL ONCOLOGY   29 巻 ( 11 ) 頁： 7180 - 7189   2022年10月

Transcriptomic profiling on localized gastric cancer identified <i>CPLX1</i> as a gene promoting malignant phenotype of gastric cancer and a predictor of recurrence after surgery and subsequent chemotherapy

Tanaka, H; Kanda, M; Shimizu, D; Tanaka, C; Inokawa, Y; Hattori, N; Hayashi, M; Nakayama, G; Kodera, Y

JOURNAL OF GASTROENTEROLOGY   57 巻 ( 9 ) 頁： 640 - 653   2022年9月

Comparison Between FOLFIRINOX and nal-IRI/FL as Second-line Treatment After Gemcitabine Plus Nab-paclitaxel for Pancreatic Cancer br

Otsu, T; Inokawa, Y; Takami, H; Hayashi, M; Kurimoto, K; Tanaka, N; Tanaka, H; Shimizu, D; Hattori, N; Kanda, M; Tanaka, C; Nakayama, G; Kodera, Y

ANTICANCER RESEARCH   42 巻 ( 8 ) 頁： 3889 - 3894   2022年8月

Expression of cellular retinoic acid binding protein 1 predicts peritoneal recurrence of gastric cancer

Sakata, K; Kanda, M; Shimizu, D; Nakamura, S; Inokawa, Y; Hattori, N; Hayashi, M; Tanaka, C; Nakayama, G; Kodera, Y

INTERNATIONAL JOURNAL OF ONCOLOGY   60 巻 ( 6 )   2022年6月

Lysosomal-associated membrane protein family member 5 promotes the metastatic potential of gastric cancer cells

Umeda, S; Kanda, M; Shimizu, D; Nakamura, S; Sawaki, K; Inokawa, Y; Hattori, N; Hayashi, M; Tanaka, C; Nakayama, G; Kodera, Y

GASTRIC CANCER   25 巻 ( 3 ) 頁： 558 - 572   2022年5月

Direct Observation of Retinal Microvessels in Cancer Patients After Systemic Administration of Bevacizumab and Oxaliplatin.

Mitsuma A, Ito Y, Shimokata T, Tanaka C, Uehara K, Nakayama G, Terasaki H, Ando Y

Cancer diagnosis & prognosis   2 巻 ( 3 ) 頁： 330 - 335   2022年5月

Drain Amylase Concentrations at 3 h After Gastrectomy Enhance Early Prediction of Postoperative Peripancreatic Inflammatory Fluid Collection

Nakanishi, K; Kanda, M; Tanaka, C; Takeda, S; Tanaka, K; Shimizu, D; Inokawa, Y; Hattori, N; Hayashi, M; Nakayama, G; Fujiwara, M; Kodera, Y

WORLD JOURNAL OF SURGERY   46 巻 ( 3 ) 頁： 648 - 655   2022年3月

The significance of the time to arterial perfusion in intraoperative ICG angiography during colorectal surgery

Aiba, T; Uehara, K; Ogura, A; Tanaka, A; Yonekawa, Y; Hattori, N; Nakayama, G; Kodera, Y; Ebata, T; Nagino, M

SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES   35 巻 ( 12 ) 頁： 7227 - 7235   2021年12月

Impact of molecular surgical margin analysis on the prediction of pancreatic cancer recurrences after pancreaticoduodenectomy

Sunagawa, Y; Hayashi, M; Yamada, S; Tanabe, H; Kurimoto, K; Tanaka, N; Sonohara, F; Inokawa, Y; Takami, H; Kanda, M; Tanaka, C; Nakayama, G; Koike, M; Kodera, Y

CLINICAL EPIGENETICS   13 巻 ( 1 ) 頁： 172   2021年12月

Neoadjuvant docetaxel, oxaliplatin plus S-1 for treating clinical stage III squamous cell carcinoma of the esophagus: Study protocol of an open-label phase II trial

Kanda, M; Shimizu, D; Miyata, K; Maeda, O; Tanaka, C; Inokawa, Y; Hattori, N; Hayashi, M; Ando, M; Kuwatsuka, Y; Murotani, K; Nakayama, G; Koike, M; Ando, Y; Ebata, T; Kodera, Y

CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS   24 巻   頁： 100853   2021年12月

Blockade of CHRNB2 signaling with a therapeutic monoclonal antibody attenuates the aggressiveness of gastric cancer cells

Kanda, M; Shimizu, D; Nakamura, S; Sawaki, K; Umeda, S; Miwa, T; Tanaka, H; Inokawa, Y; Hattori, N; Hayashi, M; Tanaka, C; Nakayama, G; Iguchi, Y; Katsuno, M; Kodera, Y

ONCOGENE   40 巻 ( 36 ) 頁： 5495 - 5504   2021年9月

A Possible Definition of Oligometastasis in Pancreatic Cancer and Associated Survival Outcomes

Yamanaka, M; Hayashi, M; Yamada, S; Sonohara, F; Takami, H; Inokawa, Y; Shimizu, D; Hattori, N; Kanda, M; Tanaka, C; Nakayama, G; Koike, M; Kodera, Y

ANTICANCER RESEARCH   41 巻 ( 8 ) 頁： 3933 - 3940   2021年8月

G-protein subunit gamma-4 expression has potential for detection, prediction and therapeutic targeting in liver metastasis of gastric cancer

Tanaka, H; Kanda, M; Miwa, T; Umeda, S; Sawaki, K; Tanaka, C; Kobayashi, D; Hayashi, M; Yamada, S; Nakayama, G; Koike, M; Kodera, Y

BRITISH JOURNAL OF CANCER   125 巻 ( 2 ) 頁： 220 - 228   2021年7月

High Serum Uric Acid Levels Could Be a Risk Factor of Hepatocellular Carcinoma Recurrences

Hayashi, M; Yamada, S; Tanabe, H; Takami, H; Inokawa, Y; Sonohara, F; Shimizu, D; Hattori, N; Kanda, M; Tanaka, C; Nakayama, G; Koike, M; Fujiwara, M; Kodera, Y

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL   73 巻 ( 6 ) 頁： 996 - 1003   2021年7月

The carcinoembryonic antigen ratio is a potential predictor of survival in recurrent colorectal cancer

Suzuki, Y; Ogura, A; Uehara, K; Aiba, T; Ohara, N; Murata, Y; Jinno, T; Mishina, T; Sato, Y; Hattori, N; Nakayama, G; Kodera, Y; Ebata, T

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY   26 巻 ( 7 ) 頁： 1264 - 1271   2021年7月

Novel prognostic implications of YTH domain family 2 in resected hepatocellular carcinoma

Nakagawa, N; Sonohara, F; Tanaka, K; Sunagawa, Y; Inokawa, Y; Takami, H; Hayashi, M; Yamada, S; Kanda, M; Tanaka, C; Nakayama, G; Koike, M; Kodera, Y

ONCOLOGY LETTERS   22 巻 ( 1 ) 頁： 538   2021年7月

<i>miR</i>-<i>23b</i>-<i>3p</i> Plays an Oncogenic Role in Hepatocellular Carcinoma

Hayashi, M; Yamada, S; Kurimoto, K; Tanabe, H; Hirabayashi, S; Sonohara, F; Inokawa, Y; Takami, H; Kanda, M; Tanaka, C; Nakayama, G; Koike, M; Kodera, Y

ANNALS OF SURGICAL ONCOLOGY   28 巻 ( 6 ) 頁： 3416 - 3426   2021年6月

Indications for neoadjuvant treatment based on risk factors for poor prognosis before and after neoadjuvant chemotherapy alone in patients with locally advanced rectal cancer

Ogura, A; Uehara, K; Aiba, T; Sando, M; Tanaka, A; Ohara, N; Murata, Y; Sato, Y; Hattori, N; Nakayama, G; Ebata, T; Kodera, Y; Nagino, M

EJSO   47 巻 ( 5 ) 頁： 1005 - 1011   2021年5月

Different Characteristics of Serum Alfa Fetoprotein and Serum Des-gamma-carboxy Prothrombin in Resected Hepatocellular Carcinoma

Hayashi, M; Yamada, S; Takano, N; Okamura, Y; Takami, H; Inokawa, Y; Sonohara, F; Tanaka, N; Shimizu, D; Hattori, N; Kanda, M; Tanaka, C; Nakayama, G; Koike, M; Kodera, Y

IN VIVO   35 巻 ( 3 ) 頁： 1749 - 1760   2021年5月

Hepatic metastasis of gastric cancer is associated with enhanced expression of ethanolamine kinase 2 via the p53-Bcl-2 intrinsic apoptosis pathway

Miwa, T; Kanda, M; Shimizu, D; Umeda, S; Sawaki, K; Tanaka, H; Tanaka, C; Hattori, N; Hayashi, M; Yamada, S; Nakayama, G; Koike, M; Kodera, Y

BRITISH JOURNAL OF CANCER   124 巻 ( 8 ) 頁： 1449 - 1460   2021年4月

Peritoneal Lavage Tumor DNA as a Novel Biomarker for Predicting Peritoneal Recurrence in Pancreatic Ductal Adenocarcinoma

Suenaga, M; Fujii, T; Yamada, S; Hayashi, M; Shinjo, K; Takami, H; Niwa, Y; Sonohara, F; Shimizu, D; Kanda, M; Kobayashi, D; Tanaka, C; Nakayama, G; Koike, M; Fujiwara, M; Kondo, Y; Kodera, Y

ANNALS OF SURGICAL ONCOLOGY   28 巻 ( 4 ) 頁： 2277 - 2286   2021年4月

Genome-wide identification and characterization of circular RNA in resected hepatocellular carcinoma and background liver tissue

Sunagawa, Y; Yamada, S; Sonohara, F; Kurimoto, K; Tanaka, N; Suzuki, Y; Inokawa, Y; Takami, H; Hayashi, M; Kanda, M; Tanaka, C; Nakayama, G; Koike, M; Kodera, Y

SCIENTIFIC REPORTS   11 巻 ( 1 ) 頁： 6016   2021年3月

Tissue <i>RNFT2</i> Expression Levels Are Associated With Peritoneal Recurrence and Poor Prognosis in Gastric Cancer

Sasahara, M; Kanda, M; Shimizu, D; Tanaka, C; Inokawa, Y; Hattori, N; Hayashi, M; Nakayama, G; Kodera, Y

ANTICANCER RESEARCH   41 巻 ( 2 ) 頁： 609 - 617   2021年2月

Development of novel combination cancer immunotherapy using anti-PD-1 and anti-PD-L1 antibody

Hasegawa, H; Sugiyama, D; Kanda, M; Hayashi, M; Tanaka, C; Yamada, S; Nakayama, G; Koike, M; Nomoto, S; Fujiwara, M; Kodera, Y; Nishikawa, H

CANCER SCIENCE   112 巻   頁： 741 - 741   2021年2月

Function and prognostic value of melanoma-associated antigen-D4 protein in esophageal squamous cell carcinoma

Sawaki, K; Kanda, M; Sato, Y; Shimizu, D; Uno, Y; Umeda, S; Hattori, N; Hayashi, M; Tanaka, C; Yamada, S; Nakayama, G; Motoyama, S; Koike, M; Fujiwara, M; Kodera, Y

CANCER SCIENCE   112 巻   頁： 531 - 531   2021年2月

Randomised phase II trial of capecitabine plus oxaliplatin with continuous versus intermittent use of oxaliplatin as adjuvant chemotherapy for stage II/III colon cancer (CCOG-1302 study)

Nakayama, G; Takano, N; Taniguchi, H; Ishigure, K; Yokoyama, H; Teramoto, H; Hashimoto, R; Sakai, M; Ishiyama, A; Kinoshita, T; Hayashi, N; Nakamura, M; Hattori, N; Sato, Y; Umeda, S; Uehara, K; Aiba, T; Sonohara, F; Hayashi, M; Kanda, M; Kobayashi, D; Tanaka, C; Yamada, S; Koike, M; Fujiwara, M; Murotani, K; Ando, M; Ando, Y; Muro, K; Kodera, Y

EUROPEAN JOURNAL OF CANCER   144 巻   頁： 61 - 71   2021年2月

Randomized phase II study comparing the efficacy and safety of SOX versus mFOLFOX6 as neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer (KSCC1301)

Miwa, K; Oki, E; Enomoto, M; Ihara, K; Ando, K; Fujita, F; Tominaga, M; Mori, S; Nakayama, G; Shimokawa, M; Saeki, H; Baba, H; Mori, M; Akagi, Y

BMC CANCER   21 巻 ( 1 ) 頁： 23   2021年1月

Perioperative assessment of indocyanine green elimination rate accurately predicts postoperative liver failure in patients undergoing hepatectomy

Sunagawa, Y; Yamada, S; Kato, Y; Sonohara, F; Takami, H; Inokawa, Y; Hayashi, M; Nakayama, G; Koike, M; Kodera, Y

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES   28 巻 ( 1 ) 頁： 86 - 94   2021年1月

Pancreatic Fat and Body Composition Measurements by Computed Tomography are Associated with Pancreatic Fistula After Pancreatectomy

Tanaka, K; Yamada, S; Sonohara, F; Takami, H; Hayashi, M; Kanda, M; Kobayashi, D; Tanaka, C; Nakayama, G; Koike, M; Fujiwara, M; Kodera, Y

ANNALS OF SURGICAL ONCOLOGY   28 巻 ( 1 ) 頁： 530 - 538   2021年1月

Age-Related Differences in the Prognosis of Pancreatic Cancer According to Perioperative Systemic Therapy

Sonohara, F; Yamada, S; Kurimoto, K; Inokawa, Y; Takami, H; Hayashi, M; Shimizu, D; Hattori, N; Kanda, M; Tanaka, C; Nakayama, G; Koike, M; Fujii, T; Kodera, Y

PANCREAS   50 巻 ( 1 ) 頁： 37 - 46   2021年1月

Novel Prognostic Implications of Methylated RNA and Demethylases in Resected HCC and Background Liver Tissue

Nakagawa, N; Tanaka, K; Sonohara, F; Kandimalla, R; Sunagawa, Y; Inokawa, Y; Takami, H; Hayashi, M; Yamada, S; Kanda, M; Tanaka, C; Nakayama, G; Koike, M; Kodera, Y

ANTICANCER RESEARCH   40 巻 ( 12 ) 頁： 6665 - 6676   2020年12月

AMIGO2 Expression as a Potential Prognostic Biomarker for Gastric Cancer

Nakamura, S; Kanda, M; Shimizu, D; Tanaka, C; Inokawa, Y; Hattori, N; Hayashi, M; Yamada, S; Nakayama, G; Omae, K; Koike, M; Kodera, Y

ANTICANCER RESEARCH   40 巻 ( 12 ) 頁： 6713 - 6721   2020年12月

What is the impact of systemic chemotherapy for lateral lymph nodes in patients with locally advanced low rectal cancer?

Ogura, A; Uehara, K; Aiba, T; Hattori, N; Nakayama, G; Maeda, O; Ando, Y; Kodera, Y; Ebata, T; Nagino, M

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE   35 巻 ( 11 ) 頁： 2073 - 2080   2020年11月

Correlation Between the Metabolic Conversion of a Capecitabine Metabolite, 5′-Deoxy-5-fluorocytidine, and Creatinine Clearance

Inaishi, T; Fujita, KI; Matsumoto, N; Shimokata, T; Maeda, O; Kikumori, T; Hattori, N; Nakayama, G; Ando, Y

IN VIVO   34 巻 ( 6 ) 頁： 3539 - 3544   2020年11月

AnOpen-Label Single-ArmPhaseIIStudy of Treatment with Neoadjuvant S-1 Plus Cisplatin for Clinical StageIIISquamous Cell Carcinoma of the Esophagus

Kanda, M; Koike, M; Iwata, N; Shimizu, D; Tanaka, C; Hattori, N; Hayashi, M; Yamada, S; Omae, K; Nakayama, G; Kodera, Y

ONCOLOGIST   25 巻 ( 11 ) 頁： E1650 - E1654   2020年11月

Characteristics Associated with Nodal and Distant Recurrence after Curative Resection of Squamous Cell Carcinoma of the Thoracic Esophagus

Kanda, M; Koike, M; Shimizu, D; Tanaka, C; Hayashi, M; Hattori, N; Yamada, S; Nakayama, G; Fujiwara, M; Kodera, Y

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS   231 巻 ( 4 ) 頁： E121 - E121   2020年10月

An outcome analysis of predictive factors for portal or splenic vein thrombosis after distal pancreatectomy

Tanaka, N; Yamada, S; Sonohara, F; Takami, H; Hayashi, M; Nakayama, G; Koike, M; Fujiwara, M; Fujii, T; Kodera, Y

SURGERY TODAY   50 巻 ( 10 ) 頁： 1282 - 1289   2020年10月

STRA6 Expression Serves as a Prognostic Biomarker of Gastric Cancer

Nakamura, S; Kanda, M; Shimizu, D; Sawaki, K; Tanaka, C; Hattori, N; Hayashi, M; Yamada, S; Nakayama, G; Omae, K; Koike, M; Kodera, Y

CANCER GENOMICS & PROTEOMICS   17 巻 ( 5 ) 頁： 509 - 516   2020年9月

The impact of cancer stem cell markers in the tissues of pancreatic ductal adenocarcinoma for prognosis after surgical resections

Inokawa, Y; Yamada, S; Hayashi, M; Sunagawa, Y; Sonohara, F; Takami, H; Hattori, N; Kanda, M; Kobayashi, D; Tanaka, C; Nakayama, G; Koike, M; Kodera, Y

CANCER RESEARCH   80 巻 ( 16 )   2020年8月

Importance of the neoadjuvant rectal (NAR) score to the outcome of neoadjuvant chemotherapy alone for locally advanced rectal cancer

Mukai, T; Uehara, K; Aiba, T; Ogura, A; Tsuzuki, T; Tanaka, A; Sando, M; Ohara, N; Sato, Y; Hattori, N; Nakayama, G; Kodera, Y; Nagino, M

SURGERY TODAY   50 巻 ( 8 ) 頁： 912 - 919   2020年8月

Tumor Location Is Associated With the Prevalence of <i>Braf</i> And <i>Pik3ca</i> Mutations in Patients with Wild-Type Ras Colorectal Cancer: A Prospective Multi-Center Cohort Study in Japan

Taniguchi, H; Uehara, K; Nakayama, G; Nakayama, H; Aiba, T; Hattori, N; Kataoka, M; Nakano, Y; Kawase, Y; Okochi, O; Matsuoka, H; Utsunomiya, S; Sakamoto, E; Mori, Y; Umeda, S; Shikano, T; Komori, K; Tajika, M; Kadowaki, S; Muro, K; Yatabe, Y

TRANSLATIONAL ONCOLOGY   13 巻 ( 7 ) 頁： 100786   2020年7月

Novel Prognostic Implications of DUPAN-2 in the Era of Initial Systemic Therapy for Pancreatic Cancer

Sunagawa, Y; Yamada, S; Sato, Y; Morimoto, D; Sonohara, F; Takami, H; Inokawa, Y; Hayashi, M; Kanda, M; Tanaka, C; Kobayashi, D; Nakayama, G; Koike, M; Fujiwara, M; Fujii, T; Kodera, Y

ANNALS OF SURGICAL ONCOLOGY   27 巻 ( 6 ) 頁： 2081 - 2089   2020年6月

Fraser extracellular matrix complex subunit 1 promotes liver metastasis of gastric cancer

Umeda, S; Kanda, M; Miwa, T; Tanaka, H; Tanaka, C; Kobayashi, D; Hayashi, M; Yamada, S; Nakayama, G; Koike, M; Kodera, Y

INTERNATIONAL JOURNAL OF CANCER   146 巻 ( 10 ) 頁： 2865 - 2876   2020年5月

Clinical impact of additional therapy for residual pancreatic cancer

Yamada, S; Sonohara, F; Tashiro, M; Murotani, K; Takami, H; Hayashi, M; Kanda, M; Tanaka, C; Kobayashi, D; Nakayama, G; Koike, M; Fujii, T; Kodera, Y

SURGERY TODAY   50 巻 ( 5 ) 頁： 440 - 448   2020年5月

Characteristics of Lung Metastasis as an Initial Recurrence Pattern After Curative Resection of Pancreatic Cancer

Morimoto, D; Yamada, S; Sonohara, F; Takami, H; Hayashi, M; Kanda, M; Tanaka, C; Kobayashi, D; Nakayama, G; Koike, M; Fujiwara, M; Fujii, T; Kodera, Y

PANCREAS   49 巻 ( 5 ) 頁： 699 - 705   2020年5月

Optimized Cutoff Value of Serum Squamous Cell Carcinoma Antigen Concentration Accurately Predicts Recurrence After Curative Resection of Squamous Cell Carcinoma of the Esophagus

Kanda, M; Koike, M; Shimizu, D; Tanaka, C; Kobayashi, D; Hattori, N; Hayashi, M; Omae, K; Yamada, S; Nakayama, G; Kodera, Y

ANNALS OF SURGICAL ONCOLOGY   27 巻 ( 4 ) 頁： 1233 - 1240   2020年4月

Exploration of Exosomal Micro RNA Biomarkers Related to Epithelial-to-Mesenchymal Transition in Pancreatic Cancer

Sonohara, F; Yamada, S; Takeda, S; Hayashi, M; Suenaga, M; Sunagawa, Y; Tashiro, M; Takami, H; Kanda, M; Tanaka, C; Kobayashi, D; Nakayama, G; Koike, M; Fujiwara, M; Kodera, Y

ANTICANCER RESEARCH   40 巻 ( 4 ) 頁： 1843 - 1853   2020年4月

Clinical Implications of Naples Prognostic Score in Patients with Resected Pancreatic Cancer

Nakagawa, N; Yamada, S; Sonohara, F; Takami, H; Hayashi, M; Kanda, M; Kobayashi, D; Tanaka, C; Nakayama, G; Koike, M; Fujiwara, M; Kodera, Y

ANNALS OF SURGICAL ONCOLOGY   27 巻 ( 3 ) 頁： 887 - 895   2020年3月

Randomized phase II trial of CAPOX with continuous versus intermittent use of oxaliplatin as an adjuvant chemotherapy after curative resection of stage II/III colon cancer (CCOG-1302 study)

Nakamura, M; Nakayama, G; Ishigure, K; Mashita, N; Yokoyama, H; Hattori, N; Uehara, K; Yamada, S; Koike, M; Kodera, Y

JOURNAL OF CLINICAL ONCOLOGY   38 巻 ( 4 )   2020年2月

Predictive value of the modified systemic inflammation score in patients undergoing curative resection of squamous cell carcinoma of the esophagus

Kanda, M; Koike, M; Shimizu, D; Tanaka, C; Kobayashi, D; Sonohara, F; Takami, H; Inokawa, Y; Hattori, N; Hayashi, M; Yamada, S; Nakayama, G; Fujiwara, M; Kodera, Y

JOURNAL OF CLINICAL ONCOLOGY   38 巻 ( 4 )   2020年2月

A prospective trial to evaluate treatment effects of a β-hydroxy-β-methylbutyrate containing nutrient for leakage a the anastomotic site after esophagectomy

Kanda, M; Koike, M; Fukaya, M; Miyata, K; Tanaka, C; Kobayashi, D; Hayashi, M; Yamada, S; Nakayama, G; Murotani, K; Fujiwara, M; Nagino, M; Kodera, Y

NAGOYA JOURNAL OF MEDICAL SCIENCE   82 巻 ( 1 ) 頁： 33 - 37   2020年2月

The Significance of Molecular Biomarkers on Clinical Survival Outcome Differs Depending on Colon Cancer Sidedness

Hirabayashi, S; Hayashi, M; Nakayama, G; Mii, S; Hattori, N; Tanabe, H; Kanda, M; Tanaka, C; Kobayashi, D; Yamada, S; Koike, M; Fujiwara, M; Takahashi, M; Kodera, Y

ANTICANCER RESEARCH   40 巻 ( 1 ) 頁： 201 - 211   2020年1月

Phase II study of capecitabine plus oxaliplatin (CapOX) as adjuvant chemotherapy for locally advanced rectal cancer (CORONA II)

Hattori, N; Nakayama, G; Uehara, K; Aiba, T; Ishigure, K; Sakamoto, E; Tojima, Y; Kanda, M; Kobayashi, D; Tanaka, C; Yamada, S; Koike, M; Fujiwara, M; Nagino, M; Kodera, Y

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY   25 巻 ( 1 ) 頁： 118 - 125   2020年1月

Peritoneal Lavage Tumor DNA as a Novel Biomarker for Predicting Peritoneal Recurrence in Pancreatic Ductal Adenocarcinoma

Suenaga, M; Fujii, T; Yamada, S; Hayashi, M; Shinjo, K; Takami, H; Niwa, Y; Sonohara, F; Shimizu, D; Kanda, M; Kobayashi, D; Tanaka, C; Nakayama, G; Koike, M; Fujiwara, M; Kondo, Y; Kodera, Y

PANCREAS   48 巻 ( 10 ) 頁： 1528 - 1528   2019年11月

Comparison of non-invasive liver reserve and fibrosis models: Implications for surgery and prognosis for hepatocellular carcinoma

Sonohara, F; Yamada, S; Tanaka, N; Tashiro, M; Sunagawa, Y; Morimoto, D; Tanaka, H; Takami, H; Hayashi, M; Kanda, M; Tanaka, C; Kobayashi, D; Nakayama, G; Koike, M; Fujiwara, M; Kodera, Y

HEPATOLOGY RESEARCH   49 巻 ( 11 ) 頁： 1305 - 1315   2019年11月

Establishment of Peritoneal and Hepatic Metastasis Mouse Xenograft Models Using Gastric Cancer Cell Lines

Miwa, T; Kanda, M; Umeda, S; Tanaka, H; Shimizu, D; Tanaka, C; Kobayashi, D; Hayashi, M; Yamada, S; Nakayama, G; Koike, M; Kodera, Y

IN VIVO   33 巻 ( 6 ) 頁： 1785 - 1792   2019年11月

Expression, Function, and Prognostic Value of MAGE-D4 Protein in Esophageal Squamous Cell Carcinoma

Uno, Y; Kanda, M; Sato, Y; Shimizu, D; Umeda, S; Hattori, N; Hayashi, M; Tanaka, C; Kobayashi, D; Yamada, S; Nakayama, G; Motoyama, S; Koike, M; Kodera, Y

ANTICANCER RESEARCH   39 巻 ( 11 ) 頁： 6015 - 6023   2019年11月

Level of Melanotransferrin in Tissue and Sera Serves as a Prognostic Marker of Gastric Cancer

Sawaki, K; Kanda, M; Umeda, S; Miwa, T; Tanaka, C; Kobayashi, D; Hayashi, M; Yamada, S; Nakayama, G; Omae, K; Koike, M; Kodera, Y

ANTICANCER RESEARCH   39 巻 ( 11 ) 頁： 6125 - 6133   2019年11月

Feasibility of subtotal esophagectomy with systematic lymphadenectomy in selected elderly patients with esophageal cancer; a propensity score matching analysis

Kanda, M; Koike, M; Tanaka, C; Kobayashi, D; Hayashi, M; Yamada, S; Nakayama, G; Omae, K; Kodera, Y

BMC SURGERY   19 巻 ( 1 ) 頁： 143   2019年10月

Randomized phase II trial of CAPOX with planned oxaliplatin stop-and-go strategy as adjuvant chemotherapy after curative resection of colon cancer (CCOG-1302 study)

Yokoyama, H; Nakayama, G; Ishigure, K; Hayashi, N; Tanaka, K; Tsutsuyama, M; Hattori, N; Yamada, S; Kodera, Y

ANNALS OF ONCOLOGY   30 巻   2019年10月

Novel implications of combined arterial resection for locally advanced pancreatic cancer in the era of newer chemo-regimens

Sonohara, F; Yamada, S; Takami, H; Hayashi, M; Kanda, M; Tanaka, C; Kobayashi, D; Nakayama, G; Koike, M; Fujiwara, M; Fujii, T; Kodera, Y

EJSO   45 巻 ( 10 ) 頁： 1895 - 1900   2019年10月

Biological and conditional factors should be included when defining criteria for resectability for patients with pancreatic cancer

Kato, Y; Yamada, S; Tashiro, M; Sonohara, F; Takami, H; Hayashi, M; Kanda, M; Kobayashi, D; Tanaka, C; Nakayama, G; Koike, M; Fujiwara, M; Kodera, Y

HPB   21 巻 ( 9 ) 頁： 1211 - 1218   2019年9月

Functions of FRAS1 as a driver gene of liver metastasis from gastric cancer analyzed by the genome editing technology

Umeda, S; Kanda, M; Tanaka, H; Sonohara, F; Takami, H; Hattori, N; Hayashi, M; Tanaka, C; Kobayashi, D; Yamada, S; Nakayama, G; Koike, M; Fujiwara, M; Kodera, Y

CANCER RESEARCH   79 巻 ( 13 )   2019年7月

Albumin-Bilirubin Score Predicts Tolerability to Adjuvant S-1 Monotherapy after Curative Gastrectomy

Miwa, T; Kanda, M; Tanaka, C; Kobayashi, D; Hayashi, M; Yamada, S; Nakayama, G; Koike, M; Kodera, Y

JOURNAL OF GASTRIC CANCER   19 巻 ( 2 ) 頁： 183 - 192   2019年6月

Homeobox C10 Influences on the Malignant Phenotype of Gastric Cancer Cell Lines and its Elevated Expression Positively Correlates with Recurrence and Poor Survival

Miwa, T; Kanda, M; Umeda, S; Tanaka, H; Tanaka, C; Kobayashi, D; Suenaga, M; Hayashi, M; Yamada, S; Nakayama, G; Koike, M; Kodera, Y

ANNALS OF SURGICAL ONCOLOGY   26 巻 ( 5 ) 頁： 1535 - 1543   2019年5月

Neoadjuvant CAPOX and bevacizumab alone for locally advanced rectal cancer: long-term results from the N-SOG 03 trial

Tomida, A; Uehara, K; Hiramatsu, K; Maeda, A; Sakamoto, E; Okada, Y; Kurumiya, Y; Nakayama, G; Nakamura, M; Aiba, T; Nagino, M

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY   24 巻 ( 4 ) 頁： 403 - 410   2019年4月

Increased Expression of <i>DNAJC12</i> is Associated with Aggressive Phenotype of Gastric Cancer

Uno, Y; Kanda, M; Miwa, T; Umeda, S; Tanaka, H; Tanaka, C; Kobayashi, D; Suenaga, M; Hattori, N; Hayashi, M; Yamada, S; Nakayama, G; Fujiwara, M; Kodera, Y

ANNALS OF SURGICAL ONCOLOGY   26 巻 ( 3 ) 頁： 836 - 844   2019年3月

Prediction of peritoneal recurrences of gastric cancer by qPCR analysis of peritoneal lavage fluids.

Nakanishi, K; Kanda, M; Umeda, S; Tanaka, C; Kobayashi, D; Hayashi, M; Yamada, S; Nakayama, G; Koike, M; Fujiwara, M; Kodera, Y

JOURNAL OF CLINICAL ONCOLOGY   37 巻 ( 4 )   2019年2月

Identification of a serum-based miRNA signature for response of esophageal squamous cell carcinoma to neoadjuvant chemotherapy

Niwa, Y; Yamada, S; Sonohara, F; Kurimoto, K; Hayashi, M; Tashiro, M; Iwata, N; Kanda, M; Tanaka, C; Kobayashi, D; Nakayama, G; Koike, M; Fujiwara, M; Kodera, Y

JOURNAL OF TRANSLATIONAL MEDICINE   17 巻 ( 1 ) 頁： 1   2019年1月

Perioperative and prognostic implication of albumin-bilirubin-TNM score in Child-Pugh class A hepatocellular carcinoma

Sonohara, F; Yamada, S; Tanaka, N; Suenaga, M; Takami, H; Hayashi, M; Niwa, Y; Sugimoto, H; Hattori, N; Kanda, M; Tanaka, C; Kobayashi, D; Nakayama, G; Koike, M; Fujiwara, M; Kodera, Y

ANNALS OF GASTROENTEROLOGICAL SURGERY   3 巻 ( 1 ) 頁： 65 - 74   2019年1月

A New Biomarker for Peritoneal Lavage Using Digital PCR in Patients with Pancreatic Ductal Adenocarcinoma

Suenaga, M; Yamada, S; Hayashi, M; Kanda, M; Tanaka, C; Nakayama, G; Koike, M; Fujiwara, M; Kodera, Y

CANCER SCIENCE   109 巻   頁： 650 - 650   2018年12月

Copine 5 expression predicts prognosis following curative resection of esophageal squamous cell carcinoma

Umeda, S; Kanda, M; Koike, M; Tanaka, H; Miwa, T; Tanaka, C; Kobayashi, D; Suenaga, M; Hayashi, M; Yamada, S; Nakayama, G; Kodera, Y

ONCOLOGY REPORTS   40 巻 ( 6 ) 頁： 3772 - 3780   2018年12月

Troponin I2 as a specific biomarker for prediction of peritoneal metastasis in gastric cancer

Sawaki, K; Kanda, M; Suenaga, M; Hayashi, M; Tanaka, C; Yamada, S; Nakayama, G; Koike, M; Fujiwara, M; Kodera, Y

CANCER SCIENCE   109 巻   頁： 765 - 765   2018年12月

Pattern-specific Transcriptomics Identifies ASGR2 as a Predictor of Hematogenous Recurrence of Gastric Cancer

Tanaka, H; Kanda, M; Suenaga, M; Hayashi, M; Tanaka, C; Yamada, S; Nakayama, G; Koike, M; Fujiwara, M; Kodera, Y

CANCER SCIENCE   109 巻   頁： 1128 - 1128   2018年12月

Integrated multigene expression panel to prognosticate patients with gastric cancer

Kanda, M; Miwa, T; Umeda, S; Tanaka, C; Hayashi, M; Suenaga, M; Yamada, S; Nakayama, G; Koike, M; Fujiwara, M; Kodera, Y

CANCER SCIENCE   109 巻   頁： 769 - 769   2018年12月

FRAS1 expression reflects the malignancy potential of gastric cancer

Umeda, S; Kanda, M; Tanaka, C; Yamada, S; Nakayama, G; Koike, M; Fujiwara, M; Kodera, Y

CANCER SCIENCE   109 巻   頁： 1128 - 1128   2018年12月

Prognostic Impact of Portal System Invasion in Pancreatic Cancer Based on Image Classification

Morimoto, D; Yamada, S; Murotani, K; Sonohara, F; Takami, H; Suenaga, M; Hayashi, M; Niwa, Y; Tashiro, M; Hattori, N; Iwata, N; Kanda, M; Tanaka, C; Kobayashi, D; Nakayama, G; Koike, M; Fujiwara, M; Fujii, T; Kodera, Y

PANCREAS   47 巻 ( 10 ) 頁： 1350 - 1356   2018年11月

Treatment strategy of intraperitoneal and systemic chemotherapy combined with gastrectomy for gastric cancer with peritoneal metastasis

Kobayashi, D; Kanda, M; Tanaka, C; Sonohara, F; Suenaga, M; Takami, H; Hattori, N; Niwa, Y; Hayashi, M; Yamada, S; Nakayama, G; Koike, M; Fujiwara, M; Kodera, Y

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY   33 巻   頁： 98 - 98   2018年11月

Transanal extended rectal surgery with lateral pelvic lymph node dissection

Aiba, T; Uehara, K; Mukai, T; Hattori, N; Nakayama, G; Nagino, M

TECHNIQUES IN COLOPROCTOLOGY   22 巻 ( 11 ) 頁： 893 - 894   2018年11月

Clinical Impact of Neoadjuvant Therapy on Nutritional Status in Pancreatic Cancer

Tashiro, M; Yamada, S; Sonohara, F; Takami, H; Suenaga, M; Hayashi, M; Niwa, Y; Tanaka, C; Kobayashi, D; Nakayama, G; Koike, M; Fujiwara, M; Fujii, T; Kodera, Y

ANNALS OF SURGICAL ONCOLOGY   25 巻 ( 11 ) 頁： 3365 - 3371   2018年10月

Expression of sushi domain containing two reflects the malignant potential of gastric cancer

Umeda, S; Kanda, M; Miwa, T; Tanaka, H; Tanaka, C; Kobayashi, D; Suenaga, M; Hattori, N; Hayashi, M; Yamada, S; Nakayama, G; Fujiwara, M; Kodera, Y

CANCER MEDICINE   7 巻 ( 10 ) 頁： 5194 - 5204   2018年10月

A longitudinal study of a new point-of-care nerve conduction device for quantitative assessment of chemotherapy-induced peripheral neurotoxicity

Matsuoka, A; Maeda, O; Mitsuma, A; Uehara, K; Nakayama, G; Nagino, M; Kodera, Y; Ando, Y

ANNALS OF ONCOLOGY   29 巻   2018年10月

Comparison of the Survival Outcomes of Pancreatic Cancer and Intraductal Papillary Mucinous Neoplasms

Yamada, S; Fujii, T; Hirakawa, A; Takami, H; Suenaga, M; Hayashi, M; Niwa, Y; Hattori, N; Iwata, N; Kanda, M; Tanaka, C; Kobayashi, D; Nakayama, G; Koike, M; Fujiwara, M; Kodera, Y

PANCREAS   47 巻 ( 8 ) 頁： 974 - 979   2018年9月

Pattern-Specific Transcriptomics Identifies <i>ASGR2</i> as a Predictor of Hematogenous Recurrence of Gastric Cancer

Tanaka, H; Kanda, M; Miwa, T; Tanaka, C; Kobayashi, D; Umeda, S; Shibata, M; Suenaga, M; Hattori, N; Hayashi, M; Iwata, N; Yamada, S; Nakayama, G; Fujiwara, M; Kodera, Y

MOLECULAR CANCER RESEARCH   16 巻 ( 9 ) 頁： 1420 - 1429   2018年9月

Impact of the Controlling Nutritional Status Score on the Prognosis After Curative Resection of Pancreatic Ductal Adenocarcinoma

Kato, Y; Yamada, S; Suenaga, M; Takami, H; Niwa, Y; Hayashi, M; Iwata, N; Kanda, M; Tanaka, C; Nakayama, G; Koike, M; Fujiwara, M; Kodera, Y

PANCREAS   47 巻 ( 7 ) 頁： 823 - 829   2018年8月

Randomized Phase II Trial of CapOX plus Bevacizumab and CapIRI plus Bevacizumab as First-Line Treatment for Japanese Patients with Metastatic Colorectal Cancer (CCOG-1201 Study)

Nakayama, G; Mitsuma, A; Sunagawa, Y; Ishigure, K; Yokoyama, H; Matsui, T; Nakayama, H; Nakata, K; Ishiyama, A; Asada, T; Umeda, S; Ezaka, K; Hattori, N; Takami, H; Kobayashi, D; Tanaka, C; Kanda, M; Yamada, S; Koike, M; Fujiwara, M; Fujii, T; Murotani, K; Ando, Y; Kodera, Y

ONCOLOGIST   23 巻 ( 8 ) 頁： 919 - 927   2018年8月

Troponin I2 as a Specific Biomarker for Prediction of Peritoneal Metastasis in Gastric Cancer

Sawaki, K; Kanda, M; Miwa, T; Umeda, S; Tanaka, H; Tanaka, C; Kobayashi, D; Suenaga, M; Hattori, N; Hayashi, M; Yamada, S; Nakayama, G; Fujiwara, M; Kodera, Y

ANNALS OF SURGICAL ONCOLOGY   25 巻 ( 7 ) 頁： 2083 - 2090   2018年7月

Clinical Implications of Lysyl Oxidase-Like Protein 2 Expression in Pancreatic Cancer

Tanaka, N; Yamada, S; Sonohara, F; Suenaga, M; Hayashi, M; Takami, H; Niwa, Y; Hattori, N; Iwata, N; Kanda, M; Tanaka, C; Kobayashi, D; Nakayama, G; Koike, M; Fujiwara, M; Fujii, T; Kodera, Y

SCIENTIFIC REPORTS   8 巻 ( 1 ) 頁： 9846   2018年6月

A Multicenter Clinical Phase II Study of FOLFOXIRI Plus Bevacizumab as First-line Therapy in Patients With Metastatic Colorectal Cancer: QUATTRO Study

Oki, E; Kato, T; Bando, H; Yoshino, T; Muro, K; Taniguchi, H; Kagawa, Y; Yamazaki, K; Yamaguchi, T; Tsuji, A; Iwamoto, S; Nakayama, G; Emi, Y; Touyama, T; Nakamura, M; Kotaka, M; Sakisaka, H; Yamanaka, T; Kanazawa, A

CLINICAL COLORECTAL CANCER   17 巻 ( 2 ) 頁： 147 - 155   2018年6月

A novel dual-marker expression panel for easy and accurate risk stratification of patients with gastric cancer

Kanda, M; Murotani, K; Tanaka, H; Miwa, T; Umeda, S; Tanaka, C; Kobayashi, D; Hayashi, M; Hattori, N; Suenaga, M; Yamada, S; Nakayama, G; Fujiwara, M; Kodera, Y

CANCER MEDICINE   7 巻 ( 6 ) 頁： 2463 - 2471   2018年6月

IDENTIFICATION OF MOLECULES DRIVING HEPATIC METASTASIS FORMATION OF GASTRIC CANCER CELLS

Kanda, M; Tanaka, C; Kobayashi, D; Suenaga, M; Takami, H; Hattori, N; Niwa, Y; Hayashi, M; Yamada, S; Nakayama, G; Koike, M; Fujiwara, M; Kodera, Y

GUT   67 巻   頁： A5 - A5   2018年6月

Significance of Lysyl oxidase-like 2 gene expression on the epithelial-mesenchymal status of hepatocellular carcinoma

Ninomiya, G; Yamada, S; Hayashi, M; Takeda, S; Suenaga, M; Takami, H; Kanda, M; Iwata, N; Niwa, Y; Tanaka, C; Kobayashi, D; Fujii, T; Nakayama, G; Sugimoto, H; Koike, M; Fujiwara, M; Kodera, Y

ONCOLOGY REPORTS   39 巻 ( 6 ) 頁： 2664 - 2672   2018年6月

Postoperative adalimumab maintenance therapy for Japanese patients with Crohn's disease: a single-center, single-arm phase II trial (CCOG-1107 study)

Asada, T; Nakayama, G; Tanaka, C; Kobayashi, D; Ezaka, K; Hattori, N; Kanda, M; Yamada, S; Koike, M; Kodera, Y

SURGERY TODAY   48 巻 ( 6 ) 頁： 609 - 617   2018年6月

Integrated multigene expression panel to prognosticate patients with gastric cancer.

Kanda M, Murotani K, Tanaka H, Miwa T, Umeda S, Tanaka C, Kobayashi D, Hayashi M, Hattori N, Suenaga M, Yamada S, Nakayama G, Fujiwara M, Kodera Y

Oncotarget   9 巻 ( 27 ) 頁： 18775-18785   2018年4月

Clinical implication of nutrition for neoadjuvant therapy and impact of nutritional support in pancreatic cancer.

Tashiro, M; Yamada, S; Fujii, T; Hattori, N; Takami, H; Suenaga, M; Niwa, Y; Hayashi, M; Iwata, N; Kanda, M; Tanaka, C; Kobayashi, D; Nakayama, G; Sugimoto, H; Koike, M; Fujiwara, M; Kodera, Y

JOURNAL OF CLINICAL ONCOLOGY   36 巻 ( 4 ) 頁： .   2018年2月

Randomized phase II trial of CapOX plus bevacizumab versus CapIRI plus bevacizumab as first-line treatment in Japanese patients with metastatic colorectal cancer (CCOG-1201).

Sasahara, M; Nakayama, G; Ishigure, K; Yokoyama, H; Uehara, K; Ishiyama, A; Matsui, T; Nakayama, H; Kobayashi, D; Umeda, S; Sunagawa, Y; Murotani, K; Ando, Y; Kodera, Y

JOURNAL OF CLINICAL ONCOLOGY   36 巻 ( 4 ) 頁： .   2018年2月

Phase II trial of oral S-1 plus bevacizumab for patients with metastatic colorectal cancer refractory to standard chemotherapies (CCOG-1105 study).

Ezaka, K; Nakayama, G; Yokoyama, H; Matsui, T; Umeda, S; Sunagawa, Y; Murotani, K; Ando, Y; Kodera, Y

JOURNAL OF CLINICAL ONCOLOGY   36 巻 ( 4 ) 頁： .   2018年2月

Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer.

Yamada, S; Fujii, T; Takano, N; Takami, H; Suenaga, M; Niwa, Y; Hayashi, M; Iwata, N; Kanda, M; Kobayashi, D; Tanaka, C; Nakayama, G; Sugimoto, H; Koike, M; Fujiwara, M; Kodera, Y

JOURNAL OF CLINICAL ONCOLOGY   36 巻 ( 4 ) 頁： .   2018年2月

Identification of a novel molecule target for the diagnosis, prediction, and treatment of hepatic metastasis of gastric cancer.

Kanda, M; Tanaka, H; Miwa, T; Kobayashi, D; Tanaka, C; Takami, H; Hayashi, M; Iwata, N; Niwa, Y; Yamada, S; Nakayama, G; Sugimoto, H; Koike, M; Fujiwara, M; Kodera, Y

JOURNAL OF CLINICAL ONCOLOGY   36 巻 ( 4 ) 頁： .   2018年2月

Effectiveness of plasma activated lactated Ringer's solution on pancreatic cancer cells in vitro and in vivo

Sato, Y; Yamada, S; Takeda, S; Kanda, M; Nakayama, G; Koike, M; Fujiwara, M; Kodera, Y

CANCER SCIENCE   109 巻   頁： 707 - 707   2018年1月

Efficacy and safety of CapeIRI plus bevacizumab therapy as a second-line treatment for patients with metastatic colorectal cancer

Sunagawa, Y; Nakayama, G; Hattori, N; Ezaka, K; Uda, H; Umeda, S; Sato, B; Yamada, S; Sugimito, H; Koike, M; Kodera, Y

ANNALS OF ONCOLOGY   28 巻   頁： .   2017年11月

Evaluation and proposal of novel resectability criteria for pancreatic cancer established by the Japan Pancreas Society

Yamada, S; Fujii, T; Takami, H; Hayashi, M; Iwata, N; Kanda, M; Tanaka, C; Sugimoto, H; Nakayama, G; Koike, M; Fujiwara, M; Kodera, Y

SURGERY   162 巻 ( 4 ) 頁： 784 - 791   2017年10月

<i>FAM46C</i> Serves as a Predictor of Hepatic Recurrence in Patients with Resectable Gastric Cancer

Tanaka, H; Kanda, M; Shimizu, D; Tanaka, C; Kobayashi, D; Hayashi, M; Iwata, N; Yamada, S; Fujii, T; Nakayama, G; Sugimoto, H; Fujiwara, M; Niwa, Y; Kodera, Y

ANNALS OF SURGICAL ONCOLOGY   24 巻 ( 11 ) 頁： 3438 - 3445   2017年10月

Involvement of the immunoregulator MZB1 in progression of gastric cancer

Tanaka, Y; Kanda, M; Tanaka, C; Kobayashi, D; Tanaka, H; Takami, H; Hayashi, M; Iwata, N; Niwa, Y; Yamada, S; Nakayama, G; Sugimoto, H; Koike, M; Fujiwara, M; Kodera, Y

ANNALS OF ONCOLOGY   28 巻   頁： .   2017年9月

Primary efficacy results and clinical impact of UGT1A1 genotype on safety from a Phase II study of FOLFOXIRI plus bevacizumab in patients with metastatic colorectal cancer: The QUATTRO study

Bando, H; Kato, T; Yoshino, T; Muro, K; Yamazaki, K; Yamaguchi, T; Oki, E; Iwamoto, S; Tsuji, A; Nakayama, G; Emi, Y; Touyama, T; Nakamura, M; Kotaka, M; Kagawa, Y; Taniguchi, H; Sakisaka, H; Yamanaka, T; Kanazawa, A

ANNALS OF ONCOLOGY   28 巻   頁： .   2017年9月

Usefulness of preoperative estimated glomerular filtration rate to predict complications after curative gastrectomy in patients with clinical T2-4 gastric cancer

Tanaka, Y; Kanda, M; Tanaka, C; Kobayashi, D; Mizuno, A; Iwata, N; Hayashi, M; Niwa, Y; Takami, H; Yamada, S; Fujii, T; Nakayama, G; Sugimoto, H; Fujiwara, M; Kodera, Y

GASTRIC CANCER   20 巻 ( 4 ) 頁： 736 - 743   2017年7月

Stapling an extracorporeal Billroth-I anastomosis by the complete double stapling technique after laparoscopy-assisted distal gastrectomy.

Tanaka C, Fujiwara M, Kanda M, Murotani K, Iwata N, Hayashi M, Kobayashi D, Yamada S, Nakayama G, Sugimoto H, Koike M, Fujii T, Kodera Y

Asian journal of endoscopic surgery   10 巻 ( 2 ) 頁： 137 - 142   2017年5月

The efficacy and safety of CapeOX plus bevacizumab therapy followed by capecitabine plus bevacizumab maintenance therapy in patients with metastatic colorectal cancer: a multi-center, single-arm, phase II study (CCOG-0902)

Nakayama, G; Ishigure, K; Yokoyama, H; Uehara, K; Kojima, H; Ishiyama, A; Hayashi, N; Takano, N; Hattori, N; Kobayashi, D; Tanaka, C; Hayashi, M; Kanda, M; Yamada, S; Sugimoto, H; Koike, M; Fujiwara, M; Fujii, T; Murotani, K; Ando, Y; Kodera, Y

BMC CANCER   17 巻 ( 1 ) 頁： 243   2017年4月

Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma: A retrospective cohort study

Ninomiya, G; Fujii, T; Yamada, S; Yabusaki, N; Suzuki, K; Iwata, N; Kanda, M; Hayashi, M; Tanaka, C; Nakayama, G; Sugimoto, H; Koike, M; Fujiwara, M; Kodera, Y

INTERNATIONAL JOURNAL OF SURGERY   39 巻   頁： 45 - 51   2017年3月

The Charlson age comorbidity index predicts prognosis in patients with resected pancreatic cancer

Asano, T; Yamada, S; Fujii, T; Yabusaki, N; Nakayama, G; Sugimoto, H; Koike, M; Fujiwara, M; Kodera, Y

INTERNATIONAL JOURNAL OF SURGERY   39 巻   頁： 169 - 175   2017年3月

<i>GPR155</i> Serves as a Predictive Biomarker for Hematogenous Metastasis in Patients with Gastric Cancer

Shimizu, D; Kanda, M; Tanaka, H; Kobayashi, D; Tanaka, C; Hayashi, M; Iwata, N; Niwa, Y; Takami, H; Yamada, S; Fujii, T; Nakayama, G; Fujiwara, M; Kodera, Y

SCIENTIFIC REPORTS   7 巻   頁： 42089   2017年2月

The Charlson age comorbidity index to predict prognosis in patients with resected pancreatic cancer.

Asano, T; Fujii, T; Yamada, S; Yabusaki, N; Ninomiya, G; Nakayama, G; Sugimoto, H; Koike, M; Fujiwara, M; Kodera, Y

JOURNAL OF CLINICAL ONCOLOGY   35 巻 ( 4 ) 頁： .   2017年2月

Tumor infiltrative pattern predicts sites of recurrence after curative gastrectomy for gastric cancer.

Kanda, M; Kobayashi, D; Tanaka, C; Yamada, S; Fujii, T; Nakayama, G; Sugimoto, H; Koike, M; Fujiwara, M; Kodera, Y

JOURNAL OF CLINICAL ONCOLOGY   35 巻 ( 4 )   2017年2月

Conversion surgery for unresectable gastric cancer following complete response of distant metastasis by systemic chemotherapy.

Kobayashi, D; Kanda, M; Tanaka, C; Iwata, N; Hayashi, M; Yamada, S; Nakayama, G; Sugimoto, H; Koike, M; Fujii, T; Fujiwara, M; Kodera, Y

JOURNAL OF CLINICAL ONCOLOGY   35 巻 ( 4 )   2017年2月

Inverse probability of treatment weighting analysis of upfront surgery versus neoadjuvant chemoradiotherapy followed by surgery for pancreatic adenocarcinoma with arterial abutment.

Fujii, T; Yamada, S; Murotani, K; Takami, H; Hayashi, M; Kanda, M; Nakayama, G; Sugimoto, H; Koike, M; Fujiwara, M; Kodera, Y

JOURNAL OF CLINICAL ONCOLOGY   35 巻 ( 4 )   2017年2月

The efficacy and safety of CapeOX plus bevacizumab therapy with a planned oxaliplatin stop-and-go strategy in patients with metastatic colorectal cancer: A multicenter, single-arm, phase II study (CCOG-0902 study).

Sunakawa, Y; Nakayama, G; Ishigure, K; Yokoyama, H; Uehara, K; Kanda, M; Murotani, K; Fujii, T; Kodera, Y

JOURNAL OF CLINICAL ONCOLOGY   35 巻 ( 4 )   2017年2月

Clinical implication of inflammation-based prognostic score and perioperative nutrition control in pancreatic cancer.

Takano, N; Yamada, S; Fujii, T; Tashiro, M; Tanaka, N; Morimoto, D; Ninomiya, G; Niwa, Y; Takami, H; Iwata, N; Hayashi, M; Kanda, M; Tanaka, C; Kobayashi, D; Nakayama, G; Sugimoto, H; Koike, M; Fujiwara, M; Kodera, Y

JOURNAL OF CLINICAL ONCOLOGY   35 巻 ( 4 )   2017年2月

Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma.

Ninomiya, G; Fujii, T; Yamada, S; Asano, T; Takano, N; Takami, H; Iwata, N; Kanda, M; Niwa, Y; Hayashi, M; Kobayashi, D; Tanaka, C; Nakayama, G; Sugimoto, H; Fujiwara, M; Koike, M; Kodera, Y

JOURNAL OF CLINICAL ONCOLOGY   35 巻 ( 4 )   2017年2月

The protein arginine methyltransferase 5 promotes malignant phenotype of hepatocellular carcinoma cells and is associated with adverse patient outcomes after curative hepatectomy

Shimizu, D; Kanda, M; Sugimoto, H; Shibata, M; Tanaka, H; Takami, H; Iwata, N; Hayashi, M; Tanaka, C; Kobayashi, D; Yamada, S; Nakayama, G; Koike, M; Fujiwara, M; Fujii, T; Kodera, Y

INTERNATIONAL JOURNAL OF ONCOLOGY   50 巻 ( 2 ) 頁： 381 - 386   2017年2月

<i>PAX5</i> gene as a novel methylation marker that predicts both clinical outcome and cisplatin sensitivity in esophageal squamous cell carcinoma

Kurimoto, K; Hayashi, M; Guerrero-Preston, R; Koike, M; Kanda, M; Hirabayashi, S; Tanabe, H; Takano, N; Iwata, N; Niwa, Y; Takami, H; Kobayashi, D; Tanaka, C; Yamada, S; Nakayama, G; Sugimoto, H; Fujii, T; Fujiwara, M; Kodera, Y

EPIGENETICS   12 巻 ( 10 ) 頁： 865 - 874   2017年